Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck EBIT 2010-2024 | MKKGY

Merck annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Merck EBIT for the quarter ending December 31, 2024 was $0.874B, a 30.99% increase year-over-year.
  • Merck EBIT for the twelve months ending December 31, 2024 was $3.945B, a 0.98% increase year-over-year.
  • Merck 2024 annual EBIT was $3.945B, a 0.98% increase from 2023.
  • Merck 2023 annual EBIT was $3.907B, a 17.11% decline from 2022.
  • Merck 2022 annual EBIT was $4.714B, a 4.64% decline from 2021.
  
Merck Annual EBIT
(Millions of US $)
2024 $3,945
2023 $3,907
2022 $4,714
2021 $4,943
2020 $3,410
2019 $2,374
2018 $2,038
2017 $2,854
2016 $2,747
2015 $2,045
2014 $2,342
2013 $2,893
2012 $1,984
2011 $1,555
2010 $12,338
2009 $10,807
Merck Quarterly EBIT
(Millions of US $)
2024-12-31 $874
2024-09-30 $1,206
2024-06-30 $854
2024-03-31 $1,011
2023-12-31 $667
2023-09-30 $1,071
2023-06-30 $1,058
2023-03-31 $1,111
2022-12-31 $904
2022-09-30 $1,244
2022-06-30 $1,249
2022-03-31 $1,316
2021-12-31 $1,186
2021-09-30 $1,236
2021-06-30 $1,264
2021-03-31 $1,257
2020-12-31 $716
2020-09-30 $1,363
2020-06-30 $541
2020-03-31 $790
2019-12-31 $572
2019-09-30 $678
2019-06-30 $695
2019-03-31 $429
2018-12-31 $361
2018-09-30 $571
2018-06-30 $469
2018-03-31 $638
2017-12-31 $301
2017-09-30 $1,058
2017-06-30 $691
2017-03-31 $805
2016-12-31 $433
2016-09-30 $754
2016-06-30 $622
2016-03-31 $937
2015-12-31 $329
2015-09-30 $644
2015-06-30 $554
2015-03-31 $573
2014-12-31 $112
2014-09-30 $569
2014-06-30 $504
2014-03-31 $644
2013-12-31 $539
2013-09-30 $830
2013-06-30 $870
2013-03-31 $643
2012-12-31 $3,646
2012-09-30 $601
2012-06-30 $79
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $151
2011-03-31 $3,505
2010-12-31 $6,234
2010-09-30 $618
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $18.475B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.625B 33.00
Zoetis (ZTS) United States $74.024B 27.92
Takeda Pharmaceutical (TAK) Japan $44.801B 9.92
Daiichi Sankyo, - (DSNKY) Japan $43.243B 26.35
Sandoz Group AG (SDZNY) Switzerland $20.284B 0.00
Astellas Pharma (ALPMY) Japan $17.608B 12.47
United Therapeutics (UTHR) United States $15.992B 15.73
Summit Therapeutics (SMMT) United States $13.894B 0.00
Shionogi (SGIOY) Japan $12.709B 12.73
Neurocrine Biosciences (NBIX) United States $11.876B 36.20
Orion OYJ (ORINY) Finland $7.630B 21.45
Madrigal Pharmaceuticals (MDGL) United States $7.026B 0.00
Corcept Therapeutics (CORT) United States $6.476B 49.06
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.416B 0.00
Stevanato Group S.p.A (STVN) Italy $6.396B 41.41
Grifols, S.A (GRFS) Spain $5.109B 0.00
Ionis Pharmaceuticals (IONS) United States $5.069B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.650B 9.52
Recursion Pharmaceuticals (RXRX) United States $3.517B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.211B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.572B 15.37
Catalyst Pharmaceuticals (CPRX) United States $2.535B 11.49
Hypermarcas (HYPMY) Brazil $2.065B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.065B 0.00
Soleno Therapeutics (SLNO) United States $1.941B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.717B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.620B 0.00
Evotec AG (EVO) Germany $1.581B 0.00
Dyne Therapeutics (DYN) United States $1.383B 0.00
Guardian Pharmacy Services (GRDN) United States $1.264B 0.00
Ardelyx (ARDX) United States $1.223B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.153B 0.00
Indivior (INDV) United States $1.138B 4.94
Ocular Therapeutix (OCUL) United States $1.058B 0.00
Xencor (XNCR) United States $1.054B 0.00
ARS Pharmaceuticals (SPRY) United States $1.053B 0.00
Enliven Therapeutics (ELVN) United States $1.043B 0.00
Harrow (HROW) United States $0.982B 0.00
Collegium Pharmaceutical (COLL) United States $0.941B 5.14
Bioventus (BVS) United States $0.814B 25.72
Avadel Pharmaceuticals (AVDL) Ireland $0.795B 0.00
Cronos Group (CRON) Canada $0.734B 0.00
Relay Therapeutics (RLAY) United States $0.649B 0.00
USANA Health Sciences (USNA) United States $0.623B 11.55
Verve Therapeutics (VERV) United States $0.595B 0.00
Xeris Biopharma Holdings (XERS) United States $0.561B 0.00
Elite Pharmaceuticals (ELTP) United States $0.526B 0.00
OmniAb (OABI) United States $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.511B 0.00
Savara (SVRA) United States $0.455B 0.00
CytoDyn (CYDY) United States $0.440B 0.00
ProKidney (PROK) United States $0.437B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.436B 0.00
Altimmune (ALT) United States $0.435B 0.00
Siga Technologies (SIGA) United States $0.406B 4.74
Organogenesis (ORGO) United States $0.400B 0.00
Zevra Therapeutics (ZVRA) United States $0.398B 0.00
Aldeyra Therapeutics (ALDX) United States $0.387B 0.00
Akebia Therapeutics (AKBA) United States $0.386B 0.00
Oruka Therapeutics (ORKA) United States $0.380B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.377B 152.79
Esperion Therapeutics (ESPR) United States $0.359B 0.00
Tourmaline Bio (TRML) United States $0.314B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.288B 0.00
Aquestive Therapeutics (AQST) United States $0.270B 0.00
Heron Therapeutics (HRTX) United States $0.269B 0.00
Nature's Sunshine Products (NATR) United States $0.255B 15.19
Avita Medical (RCEL) United States $0.247B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Korro Bio (KRRO) United States $0.239B 0.00
Profound Medical (PROF) Canada $0.224B 0.00
4D Molecular Therapeutics (FDMT) United States $0.209B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.206B 0.00
Lyell Immunopharma (LYEL) United States $0.194B 0.00
MediWound (MDWD) Israel $0.194B 0.00
Larimar Therapeutics (LRMR) United States $0.193B 0.00
Nanobiotix S.A (NBTX) France $0.182B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.178B 0.00
Inhibikase Therapeutics (IKT) United States $0.172B 0.00
Acrivon Therapeutics (ACRV) United States $0.168B 0.00
Nektar Therapeutics (NKTR) United States $0.156B 0.00
Aclaris Therapeutics (ACRS) United States $0.148B 0.00
Silence Therapeutics (SLN) United Kingdom $0.146B 0.00
Inotiv (NOTV) United States $0.137B 0.00
Champions Oncology (CSBR) United States $0.129B 0.00
Telomir Pharmaceuticals (TELO) United States $0.126B 0.00
Lexeo Therapeutics (LXEO) United States $0.123B 0.00
Cassava Sciences (SAVA) United States $0.120B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.120B 0.00
ElectroCore (ECOR) United States $0.115B 0.00
VAXART, INC (VXRT) United States $0.115B 0.00
Journey Medical (DERM) United States $0.112B 0.00
Achieve Life Sciences (ACHV) Canada $0.108B 0.00
Cardiol Therapeutics (CRDL) Canada $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.092B 0.00
Galectin Therapeutics (GALT) United States $0.092B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Metagenomi (MGX) United States $0.087B 0.00
Regulus Therapeutics (RGLS) United States $0.085B 0.00
Nutriband (NTRB) United States $0.084B 0.00
Avalo Therapeutics (AVTX) United States $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Assertio Holdings (ASRT) United States $0.076B 19.92
Karyopharm Therapeutics (KPTI) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Protara Therapeutics (TARA) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.073B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.071B 0.00
Fractyl Health (GUTS) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
Century Therapeutics (IPSC) United States $0.061B 0.00
AleAnna (ANNA) United States $0.060B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
FibroGen (FGEN) United States $0.058B 0.00
OptiNose (OPTN) United States $0.057B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
AlloVir (ALVR) United States $0.051B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
Rafael Holdings (RFL) United States $0.049B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.049B 0.00
Dominari Holdings (DOMH) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
VYNE Therapeutics (VYNE) United States $0.041B 0.00
NRx Pharmaceuticals (NRXP) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
Surrozen (SRZN) United States $0.037B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.031B 0.00
Incannex Healthcare (IXHL) Australia $0.027B 0.00
BioVie (BIVI) United States $0.027B 0.00
Jupiter Neurosciences (JUNS) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.025B 0.00
DURECT (DRRX) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.021B 0.00
Mannatech (MTEX) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Biomerica (BMRA) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Nuvilex (PMCB) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Relmada Therapeutics (RLMD) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
China SXT Pharmaceuticals (SXTC) China $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00